Thursday, March 15, 2018 9:25:09 AM
The big two pieces of news everyone is waiting on is 1) the results of ABC hospital trials and 2) approval of India government. Either one of these would be worth .05 on share price in my opinion.
A quick comparison of Sucanon vs Metformin as to which reduces blood sugar more. This is pretty unscientific but it looks like results should be very similar based on a "head-to-head" competition.
Metformin:
http://www.diabetesnet.com/about-diabetes/diabetes-medications/metformin
The 3rd paragraph says:
Metformin lowers fasting blood glucose levels by an average of 25% (17 to 37%), postprandial blood glucose up to 44.5%, and the A1c by an average of 1.5% (0.8 to 3.1%).
Sucanon:
http://www.pharmaroth.com/clinical_summary.asp
Clinical studies have shown that Sucanon® reduces blood sugar readings by about 25% - 30% and brings high blood sugar back into the normal range (non-fasting blood sugar is above 200 mg/dL (milligrams per deciliter) or fasting blood sugar is above 126 mg/dL).
More test info: http://www.pharmaroth.com/clinical_results.asp
Looks like it should be a really close competition, but even if Sucanon comes in a little worse than Metformin, Sucanon has no negative side effects.
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM